Ушбу иш иқтибос қилган ишлар

172 та иш

Иш: A systematic review of the protective effects of silymarin/silibinin against doxorubicin-induced cardiotoxicity

Silymarin preconditioning protected insulin resistant rats from liver ischemia-reperfusion injury: role of endogenous H2S
N. Younis, Mohamed A. Shaheen, Mona F. Mahmoud
Мақола20163 иқтибос
ABI
Modulatory effect of silymarin on nuclear factor-erythroid-2-related factor 2 regulated redox status, nuclear factor-κB mediated inflammation and apoptosis in experimental gastric ulcer
Walaa A. Keshk, Samer Zahran, Mohamed Katary +1
Мақола20173 иқтибос
ABI
Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats
Abeer Alanazi, Laila M. Fadda, Ahlam M. Alhusaini +3
Мақола20203 иқтибос
ABI
Evaluation of oral nano-silymarin formulation efficacy on prevention of radiotherapy induced mucositis: A randomized, double-blinded, placebo-controlled clinical trial
Sare Hosseini, Sina Rezaei, M.R. Niazi Moghadam +2
Мақола20213 иқтибос
ABI
A review on the mechanisms of the effect of silymarin in milk thistle ( Silybum marianum ) on some laboratory animals
Roshanak Khazaei, Alireza Seidavi, Mehrdad Bouyeh
Шарҳ мақола20213 иқтибос
ABI
Silymarin induces apoptosis primarily through a p53-dependent pathway involving Bcl-2/Bax, cytochrome c release, and caspase activation
Santosh K. Katiyar, Anshu M. Roy, Manjeshwar Shrinath Baliga
Мақола20053 иқтибос
ABI
Silymarin Suppresses TNF-Induced Activation of NF-κB, c-Jun N-Terminal Kinase, and Apoptosis
Sunil K. Manna, Asok Mukhopadhyay, Nguyen T. Van +1
Мақола19993 иқтибос
ABI
The Global Burden of Cancer 2013
Christina Fitzmaurice, Daniel Dicker, Amanda Pain +97
МақолаGlobal Cancer Incidence and ScreeningJAMA Oncology20152 иқтибос
ABI
Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage
Elif Tatlıdede, Özer Şehırlı, Ayliz Velioğlu‐Öğünç +5
Мақола20092 иқтибос
ABI
Silymarin causes caspases activation and apoptosis in K562 leukemia cells through inactivation of Akt pathway
Xian Zhong, Yongliang Zhu, Qinghua Lu +3
Мақола20062 иқтибос
ABI
Amelioration of doxorubicin-induced cardiotoxicity by resveratrol
Sameer Alharthi, OHOUD M. ALARABI, Wafaa S. Ramadan +5
Мақола20142 иқтибос
ABI
Inhibition of T-Cell Inflammatory Cytokines, Hepatocyte NF-κB Signaling, and HCV Infection by Standardized Silymarin
Stephen J. Polyak, Chihiro Morishima, Margaret C. Shuhart +3
Мақола20072 иқтибос
ABI
Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis
Dinesh Vyas, Gieric Laput, Arpita Vyas
Шарҳ мақола20142 иқтибос
ABI
Comparative studies of polydatin and resveratrol on mutual transformation and antioxidative effect in vivo
Huilin Wang, Jianping Gao, Yu-Liang Han +4
Мақола20152 иқтибос
ABI
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
Yanti Octavia, Carlo G. Tocchetti, Kathleen L. Gabrielson +3
Шарҳ мақола20122 иқтибос
ABI
Predictive value of p53, Bcl2 and bax in the radiotherapy of head and neck cancer
Orsolya Csuka, Éva Remenár, Krísztina Koronczay +2
Мақола19972 иқтибос
ABI
In VitroAntimicrobial and Modulatory Activity of the Natural Products Silymarin and Silibinin
Dayanne Rakelly de Oliveira, Saulo Relison Tintino, Maria Flaviana Bezerra Morais‐Braga +5
Мақола20152 иқтибос
ABI
Role of p53, Bax, p21, and DNA-PKcs in radiation sensitivity of HCT-116 cells and xenografts
Sergio Huerta, Xiaohuan Gao, Seán Dineen +3
Мақола20132 иқтибос
ABI
Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in mice through SIRT1-mediated deacetylation of p53
Chi Zhang, Yansheng Feng, Shuxin Qu +6
Мақола20112 иқтибос
ABI
Silybin and silymarin - new effects and applications
Vladimír Křen, Daniela Walterová
Шарҳ мақола20052 иқтибос
ABI
Resveratrol protects cardiomyocytes from doxorubicin-induced apoptosis through the AMPK/P53 pathway
Mi‐Hua Liu, Xiao‐Long Lin, Dongming Guo +7
Мақола20152 иқтибос
ABI
Resveratrol inhibits doxorubicin-induced cardiotoxicity via sirtuin 1 activation in H9c2 cardiomyocytes
Mi‐Hua Liu, Jian Shan, Jian Li +2
Мақола20162 иқтибос
ABI
Photodynamic Synergistic Effect of Pheophorbide a and Doxorubicin in Combined Treatment against Tumoral Cells
Rubén Ruiz‐González, Paula Milán-Rois, Roger Bresolí‐Obach +4
Мақола20172 иқтибос
ABI
Prophylactic supplementation of resveratrol is more effective than its therapeutic use against doxorubicin induced cardiotoxicity
Heba Samy Shoukry, Hania Ibrahim Ammar, Laila Ahmed Rashed +6
Мақола20172 иқтибос
ABI
A review on the effects of current chemotherapy drugs and natural agents in treating non–small cell lung cancer
Chih‐Yang Huang, Da‐Tong Ju, Chih-Fen Chang +2
Шарҳ мақола20172 иқтибос
ABI

Ушбу иш иқтибос қилган ишлар

Silymarin preconditioning protected insulin resistant rats from liver ischemia-reperfusion injury: role of endogenous H2S

Modulatory effect of silymarin on nuclear factor-erythroid-2-related factor 2 regulated redox status, nuclear factor-κB mediated inflammation and apoptosis in experimental gastric ulcer

Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats

Evaluation of oral nano-silymarin formulation efficacy on prevention of radiotherapy induced mucositis: A randomized, double-blinded, placebo-controlled clinical trial

A review on the mechanisms of the effect of silymarin in milk thistle ( <i>Silybum marianum</i> ) on some laboratory animals

Silymarin induces apoptosis primarily through a p53-dependent pathway involving Bcl-2/Bax, cytochrome <i>c</i> release, and caspase activation

Silymarin Suppresses TNF-Induced Activation of NF-κB, c-Jun N-Terminal Kinase, and Apoptosis

The Global Burden of Cancer 2013

Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage

Silymarin causes caspases activation and apoptosis in K562 leukemia cells through inactivation of Akt pathway

Amelioration of doxorubicin-induced cardiotoxicity by resveratrol

Inhibition of T-Cell Inflammatory Cytokines, Hepatocyte NF-κB Signaling, and HCV Infection by Standardized Silymarin

Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis

Comparative studies of polydatin and resveratrol on mutual transformation and antioxidative effect in vivo

Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies

Predictive value of p53, Bcl2 and bax in the radiotherapy of head and neck cancer

<i>In Vitro</i>Antimicrobial and Modulatory Activity of the Natural Products Silymarin and Silibinin

Role of p53, Bax, p21, and DNA-PKcs in radiation sensitivity of HCT-116 cells and xenografts

Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in mice through SIRT1-mediated deacetylation of p53

Silybin and silymarin - new effects and applications

Resveratrol protects cardiomyocytes from doxorubicin-induced apoptosis through the AMPK/P53 pathway

Resveratrol inhibits doxorubicin-induced cardiotoxicity via sirtuin 1 activation in H9c2 cardiomyocytes

Photodynamic Synergistic Effect of Pheophorbide a and Doxorubicin in Combined Treatment against Tumoral Cells

Prophylactic supplementation of resveratrol is more effective than its therapeutic use against doxorubicin induced cardiotoxicity

A review on the effects of current chemotherapy drugs and natural agents in treating non–small cell lung cancer